Compare Franklin FTSE South Korea ETF (FLKR) vs Immunovant Inc. Common Stock (IMVT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Franklin FTSE South Korea ETF vs Immunovant Inc. Common Stock — how do they compare? Franklin FTSE South Korea ETF trades at $58.12 (market cap $1.83B), while Immunovant Inc. Common Stock trades at $30.25 (market cap $6.25B). The key difference: Immunovant Inc. Common Stock is far larger — about 3.4× Franklin FTSE South Korea ETF's market cap, and Franklin FTSE South Korea ETF is trading nearer its 52-week high, Immunovant Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Franklin FTSE South Korea ETF for 15 Days and Immunovant Inc. Common Stock for 0 Days on average.
| FLKR | IMVT | |
|---|---|---|
Market Cap | $1.83B | $6.25B |
Volume | 679,902 | 1,755,411 |
Sector | Broad Market / Factor | Health |
52-Week High | $72.25 | $44.96 |
52-Week Low | $27.09 | $17.03 |
Typical Hold Time | 15 Days | 0 Days |
Enterprise Value | — | $5.35B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Franklin FTSE South Korea ETF
Franklin FTSE South Korea ETF seeks to track an index of South Korean equities. The fund provides exposure to companies listed in South Korea across multiple sectors.
Read more on FLKR →About Immunovant Inc. Common Stock
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →
